StonvexLoading…
StonvexStonvexStonvexCore line items from PAHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $1.30B | $1.02B | $977.89M | $942.26M |
Operating Income | $110.47M | $53.31M | $71.85M | $78.99M |
Net Income | $48.26M | $2.42M | $32.61M | $49.17M |
EPS (Diluted) | $1.19 | $0.06 | $0.81 | $1.21 |
Total Assets | $1.36B | $982.18M | $971.40M | $931.70M |
Total Liabilities | $1.08B | $725.54M | $688.89M | $669.26M |
Cash & Equivalents | $68.04M | $70.61M | $41.28M | $74.25M |
Free Cash Flow OCF − CapEx | $41.83M | $46.36M | $-38.48M | $-5.39M |
Shares Outstanding | 40.68M | 40.52M | 40.50M | 40.50M |